As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  2/5/21  American Renal Assocs Holdin… Inc 15-12B       2/5/21    1:10K                                    Broadridge Fin’l So… Inc 
 1/29/21‡ American Renal Assocs Holdin… Inc EFFECT      1/29/21    1:2K                                     SEC #5                   
 1/27/21‡ Centerbridge Credit Partners, LP  SC 13G/A               1:146K American Renal Assocs Holdin… Inc Schulte Roth & Z… LLP/FA 
 1/27/21  Centerbridge Capital Partners LP  4          10% Owner²  1:17K  American Renal Assocs Holdin… Inc Schulte Roth & Z… LLP/FA 
          Aronson Jeffrey
          CCP SBS GP, LLC
          Centerbridge Associates, L.P.
          Centerbridge Capital Partners SBS, L.P.
          Centerbridge Capital Partners Strategic LP
          Centerbridge Cayman GP Ltd.
 1/26/21  Erickson Thomas W                 4          Director²   1:6K   American Renal Assocs Holdin… Inc Broadridge Fin’l So… Inc 
 1/26/21  Hocevar Christopher J             4          Director²   1:5K   American Renal Assocs Holdin… Inc Broadridge Fin’l So… Inc 
 1/26/21  Carlucci Joseph A                 4          Dir.,Off.²  2:12K  American Renal Assocs Holdin… Inc Broadridge Fin’l So… Inc 
 1/26/21  Jureller John M                   4          Director²   1:5K   American Renal Assocs Holdin… Inc Broadridge Fin’l So… Inc 
 1/26/21  Kamal Syed T                      4          Dir.,Off.²  2:11K  American Renal Assocs Holdin… Inc Broadridge Fin’l So… Inc 
 1/26/21  Labriola Victoria                 4          Officer²    1:8K   American Renal Assocs Holdin… Inc Broadridge Fin’l So… Inc 
 1/26/21  Fish Robert H                     4          Director²   1:5K   American Renal Assocs Holdin… Inc Broadridge Fin’l So… Inc 
 1/26/21  Williamson Don E                  4          Officer²    1:8K   American Renal Assocs Holdin… Inc Broadridge Fin’l So… Inc 
 1/26/21  Boxer Michael                     4          Director²   1:7K   American Renal Assocs Holdin… Inc Broadridge Fin’l So… Inc 
 1/26/21  American Renal Assocs Holdin… Inc POS AM                 1:16K                                    Broadridge Fin’l So… Inc 
 1/26/21  American Renal Assocs Holdin… Inc S-8 POS     1/26/21    1:16K                                    Broadridge Fin’l So… Inc 
 1/26/21  New York Stock Exchange LLC       25-NSE      1/26/21    2:4K   American Renal Assocs Holdin… Inc                          
 1/26/21  American Renal Assocs Holdin… Inc 8-K:1,2,3,5 1/25/21   13:339K                                   Broadridge Fin’l So… Inc 
 1/14/21  American Renal Assocs Holdin… Inc 8-K:5       1/14/21   10:164K                                   Broadridge Fin’l So… Inc 
  1/6/21  American Renal Assocs Holdin… Inc DEFA14A      1/6/21    1:123K                                   Broadridge Fin’l So… Inc 
12/15/20  American Renal Assocs Holdin… Inc DEFM14A    12/15/20    1:3.7M                                   Broadridge Fin’l So… Inc 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	15-12B	Certification of a Termination of Registration of a Class of Securities — Form 15.
	25-NSE	Notice by a Securities Exchange of the Removal from Listing and Registration of Matured, Redeemed or Retired Securities — Form 25.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.
	DEFM14A	Definitive Proxy Statement – Merger or Acquisition — Schedule 14A.
	EFFECT	SEC Notice of Effectiveness.
	POS AM	Post-Effective Amendment of a Registration Statement.
	S-8 POS	Post-Effective Amendment of a Form S-8 Registration.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.